Healthcare Worker Safety
Irrigating wounds without proper splatter protection exposes healthcare professionals, patients and the environment to splatter and aerosolized contamination. This exposure can lead to colonization and increased risk of infection to the patient, and healthcare professionals.
IrriSept's delivery method and SplatterGuard reduce biohazard contamination that can contribute to Hospital-Acquired Infections (HAI's).
Hospitals and medical facilities nationwide have an estimated 14.2 million cases of Skin and Soft Tissue Infections (SSTIs) annually1.
In many U.S. cities, Methicillin-Resistant Staphylococcus aureus (MRSA) is now the most common pathogen isolated in the emergency department (ED) from patients with SSTIs2.
According to the Centers for Disease Control and Prevention (CDC), the main mode of transmission of MRSA is via hands (especially healthcare workers' hands) which may become contaminated by contact with Staphylococcus epidermidis3,4.
- Colonized or infected patients;
- Colonized or infected body sites of the personnel themselves; or
- Devices, items, or environmental surfaces contaminated with body fluids containing MRSA5.
In a Splatter Contamination study with Staphylococcus epidermidis, it was shown that IrriSept is bacteriostatic and bactericidal, rendering the bacteria in the splatter and aerosol contamination inert. CHG used in IrriSept has proven antimicrobial efficacy and demonstrated persistence in laboratory testing6.
1. Hersh AL, Chamber HF, Maselli JH, et al. National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infection, Arch Intern Med 2008;168:1585–91
2. Moran et al. Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department, N Engl J Med 2006;355:666-74
3. Bisaga et al. A Prevalence Study of Methicillin-Resistant Staphylococcus aureus Colonization in Emergency Department Health Care Workers, Annals of Emergency Medicine, 2008
4. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis 2008; 197:1226–34.
5. Centers for Disease Control and Prevention - Healthcare-Associated Infections (HAIs)
6. Laboratory Testing Records per USP <51>, Antimicrobial Effectiveness Testing, on file at IrriMax Corporation
